[
  {
    "ts": null,
    "headline": "Stocks to Watch Recap: UnitedHealth, SoFi, Boeing, Novo Nordisk",
    "summary": "↗️ CyberArk Software (CYBR): The Israeli cybersecurity provider's stock rose 16% after The Wall Street Journal reported that Palo Alto Networks was in talks to acquire the company. ↗️ SoFi Technologies (SOFI): The financial-technology stock gained 7% after the company raised its guidance and said profit surged fivefold in the second quarter.",
    "url": "https://finnhub.io/api/news?id=e95749fbda8034f161f1d66937ae97b0bdc5585f9ac5688b44abfc9adc56c276",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753823665,
      "headline": "Stocks to Watch Recap: UnitedHealth, SoFi, Boeing, Novo Nordisk",
      "id": 136129820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "↗️ CyberArk Software (CYBR): The Israeli cybersecurity provider's stock rose 16% after The Wall Street Journal reported that Palo Alto Networks was in talks to acquire the company. ↗️ SoFi Technologies (SOFI): The financial-technology stock gained 7% after the company raised its guidance and said profit surged fivefold in the second quarter.",
      "url": "https://finnhub.io/api/news?id=e95749fbda8034f161f1d66937ae97b0bdc5585f9ac5688b44abfc9adc56c276"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: SoFi, UnitedHealth, PayPal, Merck, Novo Nordisk, UPS, Sarepta, Boeing, Norfolk Southern, and More",
    "summary": "Revenue at SoFi jumps 44%, UnitedHealth slides after restoring financial guidance, and Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne muscular dystrophy.",
    "url": "https://finnhub.io/api/news?id=7933461d28cdb86d2b810e75f0f90556df3f50eb9eac5848fb226e2c31c07321",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753823460,
      "headline": "These Stocks Moved the Most Today: SoFi, UnitedHealth, PayPal, Merck, Novo Nordisk, UPS, Sarepta, Boeing, Norfolk Southern, and More",
      "id": 136129821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Revenue at SoFi jumps 44%, UnitedHealth slides after restoring financial guidance, and Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne muscular dystrophy.",
      "url": "https://finnhub.io/api/news?id=7933461d28cdb86d2b810e75f0f90556df3f50eb9eac5848fb226e2c31c07321"
    }
  },
  {
    "ts": null,
    "headline": "Why Merck Stock Slipped Today",
    "summary": "A change in full-year guidance by management wasn't particularly welcome.",
    "url": "https://finnhub.io/api/news?id=9ce8228e1a01aa063c5bff909d8af02cca3214afe47f7d98dd790c2e318dba07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753822072,
      "headline": "Why Merck Stock Slipped Today",
      "id": 136129856,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "A change in full-year guidance by management wasn't particularly welcome.",
      "url": "https://finnhub.io/api/news?id=9ce8228e1a01aa063c5bff909d8af02cca3214afe47f7d98dd790c2e318dba07"
    }
  },
  {
    "ts": null,
    "headline": "How major US stock indexes fared Tuesday, 7/29/2025",
    "summary": "The Dow Jones Industrial Average dropped 204 points, and the Nasdaq composite sliced 0.4% off its own record. SoFi Technologies rallied, but Merck and UPS fell following a jumbled set of profit reports. Treasury yields sank in the bond market as the Federal Reserve began a two-day meeting on interest rates.",
    "url": "https://finnhub.io/api/news?id=e67be7b4d5c86dcc39fc9869787fc452c36cdf11ffcdadcf13bf868beffc5b68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753820063,
      "headline": "How major US stock indexes fared Tuesday, 7/29/2025",
      "id": 136129857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average dropped 204 points, and the Nasdaq composite sliced 0.4% off its own record. SoFi Technologies rallied, but Merck and UPS fell following a jumbled set of profit reports. Treasury yields sank in the bond market as the Federal Reserve began a two-day meeting on interest rates.",
      "url": "https://finnhub.io/api/news?id=e67be7b4d5c86dcc39fc9869787fc452c36cdf11ffcdadcf13bf868beffc5b68"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: S&P 500 snaps 6-day record streak, stocks fall as earnings flood in, Fed decision looms",
    "summary": "Wall Street digested major earnings and economic data ahead of a blockbuster week that could shake markets.",
    "url": "https://finnhub.io/api/news?id=2c8f96022564ff8a3907deea2820056017da3381a7df9bcb1c7753ad814d4d51",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753819452,
      "headline": "Stock market today: S&P 500 snaps 6-day record streak, stocks fall as earnings flood in, Fed decision looms",
      "id": 136129858,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Wall Street digested major earnings and economic data ahead of a blockbuster week that could shake markets.",
      "url": "https://finnhub.io/api/news?id=2c8f96022564ff8a3907deea2820056017da3381a7df9bcb1c7753ad814d4d51"
    }
  },
  {
    "ts": null,
    "headline": "Pharma tariffs would be 'counterproductive,' industry rep. says",
    "summary": "Uncertainty about pharmaceutical tariffs continues to loom over the pharmaceutical industry, with some companies committing to invest in the US to possibly avoid levies. Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani examines how the industry is approaching possible tariffs. Check out Yahoo Finance's interview with AstraZeneca (AZN) CFO Aradhana Sarin here. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=aa3ef4679e5591b40c2382bb110dd3bcaae48ac7d47909c2b3b9965de8e2bd02",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753819223,
      "headline": "Pharma tariffs would be 'counterproductive,' industry rep. says",
      "id": 136129859,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Uncertainty about pharmaceutical tariffs continues to loom over the pharmaceutical industry, with some companies committing to invest in the US to possibly avoid levies. Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani examines how the industry is approaching possible tariffs. Check out Yahoo Finance's interview with AstraZeneca (AZN) CFO Aradhana Sarin here. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=aa3ef4679e5591b40c2382bb110dd3bcaae48ac7d47909c2b3b9965de8e2bd02"
    }
  },
  {
    "ts": null,
    "headline": "Merck's $3B Shock Move: Is This the End of the Keytruda Era?",
    "summary": "Facing a post-Keytruda cliff and China setbacks, Merck slashes billions and doubles down on risky reinvention.",
    "url": "https://finnhub.io/api/news?id=4deb94ed8e10814045904efed061e531b22565b33b6deadd82f7176faec0cc97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753818209,
      "headline": "Merck's $3B Shock Move: Is This the End of the Keytruda Era?",
      "id": 136129860,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Facing a post-Keytruda cliff and China setbacks, Merck slashes billions and doubles down on risky reinvention.",
      "url": "https://finnhub.io/api/news?id=4deb94ed8e10814045904efed061e531b22565b33b6deadd82f7176faec0cc97"
    }
  },
  {
    "ts": null,
    "headline": "Why Merck (MRK) Shares Are Sliding Today",
    "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) fell 3.2% in the afternoon session after the company reported second-quarter financial results that missed revenue expectations and revealed a new multi-year cost-cutting initiative. The pharmaceutical giant posted total sales of $15.8 billion, representing a 2% decrease from the same period last year. This revenue shortfall was primarily driven by a steep 55% drop in sales for its Gardasil vaccine, which faced declining demand in China. W",
    "url": "https://finnhub.io/api/news?id=df785a639021f0e1030dd80a77925ab57704e258cfcd4efea26a685eeb727ff4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753814459,
      "headline": "Why Merck (MRK) Shares Are Sliding Today",
      "id": 136129861,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) fell 3.2% in the afternoon session after the company reported second-quarter financial results that missed revenue expectations and revealed a new multi-year cost-cutting initiative. The pharmaceutical giant posted total sales of $15.8 billion, representing a 2% decrease from the same period last year. This revenue shortfall was primarily driven by a steep 55% drop in sales for its Gardasil vaccine, which faced declining demand in China. W",
      "url": "https://finnhub.io/api/news?id=df785a639021f0e1030dd80a77925ab57704e258cfcd4efea26a685eeb727ff4"
    }
  },
  {
    "ts": null,
    "headline": "1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year",
    "summary": "This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.",
    "url": "https://finnhub.io/api/news?id=5d21834ef105236d17ec2d88dd30b79123f2f45f927f7800826da97f3ebd928f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753813674,
      "headline": "1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year",
      "id": 136129862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.",
      "url": "https://finnhub.io/api/news?id=5d21834ef105236d17ec2d88dd30b79123f2f45f927f7800826da97f3ebd928f"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Reports Decline in Q2 Earnings & Updates 2025 Sales Guidance",
    "summary": "Merck (MRK) has recently reported a decline in both quarterly sales and net income, coupled with a narrowed sales guidance for 2025. Despite these announcements, the company's stock price moved up by 6% over the last month, suggesting investor sentiment may have been bolstered by other developments. Notably, the approval of KEYTRUDA® for cervical cancer by Health Canada and the initiation of the EXPrESSIVE Phase 3 Trials were key positive product-related news during this period. Additionally,...",
    "url": "https://finnhub.io/api/news?id=9a3d78189a6f99b4a4c3fad93d85e0a8e796251ee73bec59fc1abfd5156d7ff3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753810481,
      "headline": "Merck (MRK) Reports Decline in Q2 Earnings & Updates 2025 Sales Guidance",
      "id": 136129863,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) has recently reported a decline in both quarterly sales and net income, coupled with a narrowed sales guidance for 2025. Despite these announcements, the company's stock price moved up by 6% over the last month, suggesting investor sentiment may have been bolstered by other developments. Notably, the approval of KEYTRUDA® for cervical cancer by Health Canada and the initiation of the EXPrESSIVE Phase 3 Trials were key positive product-related news during this period. Additionally,...",
      "url": "https://finnhub.io/api/news?id=9a3d78189a6f99b4a4c3fad93d85e0a8e796251ee73bec59fc1abfd5156d7ff3"
    }
  },
  {
    "ts": null,
    "headline": "Update: Merck Shares Fall After Optimization Initiative, Lower Q2 Results, Gardasil Sales Decline",
    "summary": "(Updates with latest stock movement and additional details in the first and second paragraph.) Me",
    "url": "https://finnhub.io/api/news?id=86e96d6aa5478ff586acf7b792da70948dde58f00d26fb53c50e5ef551606786",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753810389,
      "headline": "Update: Merck Shares Fall After Optimization Initiative, Lower Q2 Results, Gardasil Sales Decline",
      "id": 136129864,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "(Updates with latest stock movement and additional details in the first and second paragraph.) Me",
      "url": "https://finnhub.io/api/news?id=86e96d6aa5478ff586acf7b792da70948dde58f00d26fb53c50e5ef551606786"
    }
  },
  {
    "ts": null,
    "headline": "Stock market today: Dow, S&P 500, Nasdaq slip as earnings roll in, Fed decision looms",
    "summary": "Wall Street digested major earnings and economic data ahead of a blockbuster week that could shake markets.",
    "url": "https://finnhub.io/api/news?id=49ebfe785813c6a865408642cea327227d0c2287737ebe69437fc17b3fe7f766",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753808178,
      "headline": "Stock market today: Dow, S&P 500, Nasdaq slip as earnings roll in, Fed decision looms",
      "id": 136118960,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Wall Street digested major earnings and economic data ahead of a blockbuster week that could shake markets.",
      "url": "https://finnhub.io/api/news?id=49ebfe785813c6a865408642cea327227d0c2287737ebe69437fc17b3fe7f766"
    }
  },
  {
    "ts": null,
    "headline": "FTSE 100 climbs as earnings cascade brings cheer",
    "summary": "Shares of Games Workshop, AstraZeneca, Barclays and Entain moved higher.",
    "url": "https://finnhub.io/api/news?id=cf5617b691b88af78cfa526265e2c2fbf9041eb82916ac8e6b8ebf0a5cf16684",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753806978,
      "headline": "FTSE 100 climbs as earnings cascade brings cheer",
      "id": 136119256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Shares of Games Workshop, AstraZeneca, Barclays and Entain moved higher.",
      "url": "https://finnhub.io/api/news?id=cf5617b691b88af78cfa526265e2c2fbf9041eb82916ac8e6b8ebf0a5cf16684"
    }
  },
  {
    "ts": null,
    "headline": "Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop",
    "summary": "Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop",
    "url": "https://finnhub.io/api/news?id=8cb8d85684fba5cb6f13de5ba46a7d38c755802481d6b15369405b987384278e",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753805743,
      "headline": "Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop",
      "id": 136134614,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop",
      "url": "https://finnhub.io/api/news?id=8cb8d85684fba5cb6f13de5ba46a7d38c755802481d6b15369405b987384278e"
    }
  },
  {
    "ts": null,
    "headline": "Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed",
    "summary": "MRK beats second-quarter estimates for EPS while matching the same for sales. The company trims its 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=51f771915450e445519354a99f66d13e066654ddffacbeedc19d337bb93c91bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753805400,
      "headline": "Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed",
      "id": 136129865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MRK beats second-quarter estimates for EPS while matching the same for sales. The company trims its 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=51f771915450e445519354a99f66d13e066654ddffacbeedc19d337bb93c91bb"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: US June Advance Trade Gap Narrows; Novo Nordisk Q2 Earnings Miss Estimates, Names New CEO",
    "summary": "All three major US stock indexes were down in late-morning trading on Tuesday as traders digested ne",
    "url": "https://finnhub.io/api/news?id=182b81511539b254ca451243c08f5ac68675f2adc8bcb7552b65612beb4800b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753803887,
      "headline": "Top Midday Stories: US June Advance Trade Gap Narrows; Novo Nordisk Q2 Earnings Miss Estimates, Names New CEO",
      "id": 136119173,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were down in late-morning trading on Tuesday as traders digested ne",
      "url": "https://finnhub.io/api/news?id=182b81511539b254ca451243c08f5ac68675f2adc8bcb7552b65612beb4800b6"
    }
  },
  {
    "ts": null,
    "headline": "Royal Caribbean, Merck, FuboTV: Trending Tickers",
    "summary": "Royal Caribbean (RCL) stock falls despite the company lifting its full-year outlook. Merck (MRK) stock is dipping after the company announced it will cut jobs as part of its larger cost-cutting plan. This news comes ahead of Merck's $10 billion acquisition of Verona Pharma (VRNA). FuboTV (FUBO) released its preliminary second quarter results, which were better than previous expectations. FuboTV stock is trading higher in Tuesday's session on the news, and the company's full report will be released on Tuesday, Aug. 8. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here.",
    "url": "https://finnhub.io/api/news?id=09997d3873432ee91c55f4e9aba008d0cf0b260f17a453c5481daa299bf794fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753803753,
      "headline": "Royal Caribbean, Merck, FuboTV: Trending Tickers",
      "id": 136119258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Royal Caribbean (RCL) stock falls despite the company lifting its full-year outlook. Merck (MRK) stock is dipping after the company announced it will cut jobs as part of its larger cost-cutting plan. This news comes ahead of Merck's $10 billion acquisition of Verona Pharma (VRNA). FuboTV (FUBO) released its preliminary second quarter results, which were better than previous expectations. FuboTV stock is trading higher in Tuesday's session on the news, and the company's full report will be released on Tuesday, Aug. 8. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here.",
      "url": "https://finnhub.io/api/news?id=09997d3873432ee91c55f4e9aba008d0cf0b260f17a453c5481daa299bf794fe"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: UnitedHealth, Sarepta, UPS, Whirlpool, VeriSign, Cadence Design, Exelixis, and More",
    "summary": "UnitedHealth restores financial guidance, Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne muscular dystrophy, and Whirlpool sinks after reducing full-year earnings guidance.",
    "url": "https://finnhub.io/api/news?id=ffb4fdbd1f7b018ca036f63f59f1a055e2a6ecc122bbac5beb365e7482f5bc11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753784220,
      "headline": "These Stocks Are Moving the Most Today: UnitedHealth, Sarepta, UPS, Whirlpool, VeriSign, Cadence Design, Exelixis, and More",
      "id": 136117026,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "UnitedHealth restores financial guidance, Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne muscular dystrophy, and Whirlpool sinks after reducing full-year earnings guidance.",
      "url": "https://finnhub.io/api/news?id=ffb4fdbd1f7b018ca036f63f59f1a055e2a6ecc122bbac5beb365e7482f5bc11"
    }
  },
  {
    "ts": null,
    "headline": "Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.",
    "summary": "There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.",
    "url": "https://finnhub.io/api/news?id=2882e025de234379523055e798c0734413f211014488659f7fbc8603b3ac1eda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753802160,
      "headline": "Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.",
      "id": 136119118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.",
      "url": "https://finnhub.io/api/news?id=2882e025de234379523055e798c0734413f211014488659f7fbc8603b3ac1eda"
    }
  },
  {
    "ts": null,
    "headline": "Merck Stock Is Almost A Classical Benjamin Graham Investment",
    "summary": "Discover why Merck is a strong, profitable pick meeting Benjamin Graham's criteria, but stay aware of potential downside risks before investing.",
    "url": "https://finnhub.io/api/news?id=9001f2a23e0d62242e5f8fcec85779826b7440c6106b9655112515a28c4f5fda",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753801439,
      "headline": "Merck Stock Is Almost A Classical Benjamin Graham Investment",
      "id": 136120939,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210931291/image_1210931291.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Discover why Merck is a strong, profitable pick meeting Benjamin Graham's criteria, but stay aware of potential downside risks before investing.",
      "url": "https://finnhub.io/api/news?id=9001f2a23e0d62242e5f8fcec85779826b7440c6106b9655112515a28c4f5fda"
    }
  },
  {
    "ts": null,
    "headline": "Bispecific Antibodies Market Report 2025- 2035, with Profiles of Akeso Biopharma, Alexion, Amgen, Genmab, Immunocore, Linton Pharm, Merck, OncXerna Therapeutics, Zymeworks, and More",
    "summary": "The global bispecific antibodies market, valued at USD 5.6 billion in 2025, is set to soar to USD 16.8 billion by 2035, growing at a CAGR of 9.5%. Key drivers include advancements in monoclonal antibodies and strategic partnerships. North America leads, with hematological malignancies emerging rapidly. Bispecific Antibodies Market Development Pipeline Bispecific Antibodies Market Development Pipeline Bispecific Antibodies Market Distribution Bispecific Antibodies Market Distribution Dublin, July",
    "url": "https://finnhub.io/api/news?id=95cf96abdce4c5fb35d78ebfc3e27c013a4aeff7ed1b71a043d4cd0daaff100f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753801380,
      "headline": "Bispecific Antibodies Market Report 2025- 2035, with Profiles of Akeso Biopharma, Alexion, Amgen, Genmab, Immunocore, Linton Pharm, Merck, OncXerna Therapeutics, Zymeworks, and More",
      "id": 136119261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The global bispecific antibodies market, valued at USD 5.6 billion in 2025, is set to soar to USD 16.8 billion by 2035, growing at a CAGR of 9.5%. Key drivers include advancements in monoclonal antibodies and strategic partnerships. North America leads, with hematological malignancies emerging rapidly. Bispecific Antibodies Market Development Pipeline Bispecific Antibodies Market Development Pipeline Bispecific Antibodies Market Distribution Bispecific Antibodies Market Distribution Dublin, July",
      "url": "https://finnhub.io/api/news?id=95cf96abdce4c5fb35d78ebfc3e27c013a4aeff7ed1b71a043d4cd0daaff100f"
    }
  },
  {
    "ts": null,
    "headline": "Merck Shares Fall After Optimization Initiative, Lower Q2 Results",
    "summary": "Merck (MRK) shares were down more than 4% in recent trading Tuesday after the company announced a mu",
    "url": "https://finnhub.io/api/news?id=d9a1398ffe78a6e9cd91c5f971db163c1ad40ea9b868484021e5b1ff40bdac80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753801002,
      "headline": "Merck Shares Fall After Optimization Initiative, Lower Q2 Results",
      "id": 136119262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) shares were down more than 4% in recent trading Tuesday after the company announced a mu",
      "url": "https://finnhub.io/api/news?id=d9a1398ffe78a6e9cd91c5f971db163c1ad40ea9b868484021e5b1ff40bdac80"
    }
  },
  {
    "ts": null,
    "headline": "Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges",
    "summary": "Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst consensus but overall sales experiencing a slight year-over-year decline and missing revenue expectations. The market’s cautious reaction underscores investor scrutiny of the company’s performance, particularly a significant drop in Gardasil vaccine sales, even as its blockbuster cancer drug Keytruda co",
    "url": "https://finnhub.io/api/news?id=8424353c869258435fcb566396c9cedb69be02b9c944ce0ee5e00616fc90eedf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753800334,
      "headline": "Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges",
      "id": 136119263,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst consensus but overall sales experiencing a slight year-over-year decline and missing revenue expectations. The market’s cautious reaction underscores investor scrutiny of the company’s performance, particularly a significant drop in Gardasil vaccine sales, even as its blockbuster cancer drug Keytruda co",
      "url": "https://finnhub.io/api/news?id=8424353c869258435fcb566396c9cedb69be02b9c944ce0ee5e00616fc90eedf"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Tuesday: UnitedHealth, P&G, Spotify, UPS",
    "summary": "↘️ UnitedHealth (UNH): The healthcare conglomerate reinstated its financial guidance, giving an estimate for annual adjusted earnings well below its original forecast. Shares, which have shed more than 40% this year, dropped in premarket trading.",
    "url": "https://finnhub.io/api/news?id=22b356aa893ba6c976c552b3f4c6de6d33fade94c9803dda4a2d0d6984323465",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753786691,
      "headline": "Stocks to Watch Tuesday: UnitedHealth, P&G, Spotify, UPS",
      "id": 136116989,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "↘️ UnitedHealth (UNH): The healthcare conglomerate reinstated its financial guidance, giving an estimate for annual adjusted earnings well below its original forecast. Shares, which have shed more than 40% this year, dropped in premarket trading.",
      "url": "https://finnhub.io/api/news?id=22b356aa893ba6c976c552b3f4c6de6d33fade94c9803dda4a2d0d6984323465"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript",
    "summary": "Merck &amp; Co., Inc. (NYSE:MRK) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ETCompany ParticipantsCaroline A.",
    "url": "https://finnhub.io/api/news?id=638615cd8f597658fb95c35606ef4106df38b3ff08f3436a67b767e049422523",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796860,
      "headline": "Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript",
      "id": 136120388,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck &amp; Co., Inc. (NYSE:MRK) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ETCompany ParticipantsCaroline A.",
      "url": "https://finnhub.io/api/news?id=638615cd8f597658fb95c35606ef4106df38b3ff08f3436a67b767e049422523"
    }
  },
  {
    "ts": null,
    "headline": "Dow down nearly 250 points on losses in shares of UnitedHealth, Boeing",
    "summary": "Dow down nearly 250 points on losses in shares of UnitedHealth, Boeing",
    "url": "https://finnhub.io/api/news?id=5c9c215cf0946a30b393cc210a24350a2fe2d29ac3e2f90c9c6c05db826bef63",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796580,
      "headline": "Dow down nearly 250 points on losses in shares of UnitedHealth, Boeing",
      "id": 136134645,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow down nearly 250 points on losses in shares of UnitedHealth, Boeing",
      "url": "https://finnhub.io/api/news?id=5c9c215cf0946a30b393cc210a24350a2fe2d29ac3e2f90c9c6c05db826bef63"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Keep Grinding Higher at the Open",
    "summary": "The stock market’s march higher continued on Tuesday as Wall Street digested the latest wave of earnings and tariff news.  The Dow Jones Industrial Average was moving in and out of negative territory.  The Nasdaq Composite was up 0.5%.",
    "url": "https://finnhub.io/api/news?id=987945a4dbc4e58f93d572386e3f4b663f9f8f10c2cd4fe6382e5b65ed3d7a80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753796558,
      "headline": "Stocks Keep Grinding Higher at the Open",
      "id": 136118997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The stock market’s march higher continued on Tuesday as Wall Street digested the latest wave of earnings and tariff news.  The Dow Jones Industrial Average was moving in and out of negative territory.  The Nasdaq Composite was up 0.5%.",
      "url": "https://finnhub.io/api/news?id=987945a4dbc4e58f93d572386e3f4b663f9f8f10c2cd4fe6382e5b65ed3d7a80"
    }
  },
  {
    "ts": null,
    "headline": "Here's What Key Metrics Tell Us About Merck (MRK) Q2 Earnings",
    "summary": "Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=244989a522b3604e7892f1b6738ddcad81761f4bbe9eb770ea1da6db794659d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753795810,
      "headline": "Here's What Key Metrics Tell Us About Merck (MRK) Q2 Earnings",
      "id": 136119267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=244989a522b3604e7892f1b6738ddcad81761f4bbe9eb770ea1da6db794659d6"
    }
  },
  {
    "ts": null,
    "headline": "AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform",
    "summary": "AZN's second-quarter revenues beat on strong drug sales across Oncology and CVRM despite in-line earnings.",
    "url": "https://finnhub.io/api/news?id=3e299ccaa83c78b9f433c0100eeed63b029cef2e16343d3ebeaa1417c6841b21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794720,
      "headline": "AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform",
      "id": 136119268,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "AZN's second-quarter revenues beat on strong drug sales across Oncology and CVRM despite in-line earnings.",
      "url": "https://finnhub.io/api/news?id=3e299ccaa83c78b9f433c0100eeed63b029cef2e16343d3ebeaa1417c6841b21"
    }
  },
  {
    "ts": null,
    "headline": "Market Movers: Major companies release earnings",
    "summary": "A closer focus at some of the companies who released earnings reports today. United Health (UEEC), Spotify (SPOT), UPS (UPS), Paypal (PYPL), Proctor&Gamble (PG), Merck (MRK) and SOFI (SOFI).",
    "url": "https://finnhub.io/api/news?id=cc367d01dbfdee604b20da10f8ee2b8d0179a1df43f04feb484c31e76c50b958",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794540,
      "headline": "Market Movers: Major companies release earnings",
      "id": 136117858,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "A closer focus at some of the companies who released earnings reports today. United Health (UEEC), Spotify (SPOT), UPS (UPS), Paypal (PYPL), Proctor&Gamble (PG), Merck (MRK) and SOFI (SOFI).",
      "url": "https://finnhub.io/api/news?id=cc367d01dbfdee604b20da10f8ee2b8d0179a1df43f04feb484c31e76c50b958"
    }
  },
  {
    "ts": null,
    "headline": "Correction: Earnings, Trade Outlook Lift Wall Street Pre-Bell; Asia Mixed, Europe Up",
    "summary": "(Corrects the month for the Case-Shiller Home Price Index and the FHFA House Price Index in the elev",
    "url": "https://finnhub.io/api/news?id=b948deef3b483e906a91e22fb8b623ed8122823e2c917aab3f69d228d47d6d25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753792025,
      "headline": "Correction: Earnings, Trade Outlook Lift Wall Street Pre-Bell; Asia Mixed, Europe Up",
      "id": 136119270,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "(Corrects the month for the Case-Shiller Home Price Index and the FHFA House Price Index in the elev",
      "url": "https://finnhub.io/api/news?id=b948deef3b483e906a91e22fb8b623ed8122823e2c917aab3f69d228d47d6d25"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?",
    "summary": "MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline milestones.",
    "url": "https://finnhub.io/api/news?id=b907ff4df86d247236f04e8fce52bfa216457f8eb54af620ba725c09494accbd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753791960,
      "headline": "Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?",
      "id": 136119271,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline milestones.",
      "url": "https://finnhub.io/api/news?id=b907ff4df86d247236f04e8fce52bfa216457f8eb54af620ba725c09494accbd"
    }
  },
  {
    "ts": null,
    "headline": "Merck plans spending shift to boost business beyond Keytruda",
    "summary": "Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support of newer drugs and R&D.",
    "url": "https://finnhub.io/api/news?id=ed279f6879317598d6fb7a3b3e15890ca33752402ed5b0b9e7746535147844a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753791180,
      "headline": "Merck plans spending shift to boost business beyond Keytruda",
      "id": 136119272,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support of newer drugs and R&D.",
      "url": "https://finnhub.io/api/news?id=ed279f6879317598d6fb7a3b3e15890ca33752402ed5b0b9e7746535147844a5"
    }
  },
  {
    "ts": null,
    "headline": "Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer",
    "summary": "SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for the pivotal TACTI-004 (KEYNOTE-F91) Phase III trial at the IASLC 2025 World Conference on Lung Cancer (WCLC), taking place in Barcelona, Spain, from 6-9 September 2025. The Trial in Progress poster includes an overview and study design of the TACT",
    "url": "https://finnhub.io/api/news?id=4a460cc5d7ce7bdfd9521d165297dc841e4b70296e65da0348a41515b15059f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753790400,
      "headline": "Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the 2025 World Conference on Lung Cancer",
      "id": 136117055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "SYDNEY, AUSTRALIA, July 29, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for the pivotal TACTI-004 (KEYNOTE-F91) Phase III trial at the IASLC 2025 World Conference on Lung Cancer (WCLC), taking place in Barcelona, Spain, from 6-9 September 2025. The Trial in Progress poster includes an overview and study design of the TACT",
      "url": "https://finnhub.io/api/news?id=4a460cc5d7ce7bdfd9521d165297dc841e4b70296e65da0348a41515b15059f9"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Tops Q2 Earnings Estimates",
    "summary": "Merck (MRK) delivered earnings and revenue surprises of +5.97% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=4c5ab90c0ae1ef4783d9d88bf3ba75beca9ee6250e11d8052fa941dab1dd7878",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753789202,
      "headline": "Merck (MRK) Tops Q2 Earnings Estimates",
      "id": 136119273,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) delivered earnings and revenue surprises of +5.97% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=4c5ab90c0ae1ef4783d9d88bf3ba75beca9ee6250e11d8052fa941dab1dd7878"
    }
  },
  {
    "ts": null,
    "headline": "Earnings, Trade Outlook Lift Wall Street Pre-Bell; Asia Mixed, Europe Up",
    "summary": "Wall Street futures again pointed to fresh all-time records pre-bell Tuesday, as traders digested a",
    "url": "https://finnhub.io/api/news?id=038d96538abf1e3da907e57d41372911f8df81b5aba831686ca273e371347139",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753789072,
      "headline": "Earnings, Trade Outlook Lift Wall Street Pre-Bell; Asia Mixed, Europe Up",
      "id": 136117056,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Wall Street futures again pointed to fresh all-time records pre-bell Tuesday, as traders digested a",
      "url": "https://finnhub.io/api/news?id=038d96538abf1e3da907e57d41372911f8df81b5aba831686ca273e371347139"
    }
  },
  {
    "ts": null,
    "headline": "Merck narrows 2025 outlook, announces $3bn cost-saving initiative",
    "summary": "Investing.com -- Merck (NYSE:MRK) on Tuesday reported second-quarter earnings and revenue that beat and missed analyst expectations, respectively, while narrowing its outlook for the year.",
    "url": "https://finnhub.io/api/news?id=a71f97a20d6ca9c628c4ecad9b5c7f3dcb0cd5a5529b8914082915daf04bab1a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753787532,
      "headline": "Merck narrows 2025 outlook, announces $3bn cost-saving initiative",
      "id": 136117057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Investing.com -- Merck (NYSE:MRK) on Tuesday reported second-quarter earnings and revenue that beat and missed analyst expectations, respectively, while narrowing its outlook for the year.",
      "url": "https://finnhub.io/api/news?id=a71f97a20d6ca9c628c4ecad9b5c7f3dcb0cd5a5529b8914082915daf04bab1a"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Gain Pre-Bell as Investors Monitor Latest US-China Trade Talks; Fed Meeting, Earnings on Deck",
    "summary": "US equity futures were trending higher on Tuesday as investors monitor developments in the latest ro",
    "url": "https://finnhub.io/api/news?id=6a136aea03c664fe54df21f55334aeeaa8362934b58b580abadeb0c7eaceb4d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753787504,
      "headline": "Stocks Gain Pre-Bell as Investors Monitor Latest US-China Trade Talks; Fed Meeting, Earnings on Deck",
      "id": 136116859,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "US equity futures were trending higher on Tuesday as investors monitor developments in the latest ro",
      "url": "https://finnhub.io/api/news?id=6a136aea03c664fe54df21f55334aeeaa8362934b58b580abadeb0c7eaceb4d9"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: UnitedHealth Shares Struggle Following Weak 2025 Outlook",
    "summary": "UnitedHealth shares continue to struggle after the company issued a fresh outlook for 2025, indicating revenue and adjusted earnings below Street forecasts.",
    "url": "https://finnhub.io/api/news?id=756d723020dae9f74b0f82f62972f7ce86787c5810d92bb3affd39ae16224c95",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753787444,
      "headline": "Wall Street Lunch: UnitedHealth Shares Struggle Following Weak 2025 Outlook",
      "id": 136118531,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442861078/image_1442861078.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "UnitedHealth shares continue to struggle after the company issued a fresh outlook for 2025, indicating revenue and adjusted earnings below Street forecasts.",
      "url": "https://finnhub.io/api/news?id=756d723020dae9f74b0f82f62972f7ce86787c5810d92bb3affd39ae16224c95"
    }
  },
  {
    "ts": null,
    "headline": "Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations",
    "summary": "Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% year on year to $15.81 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $64.8 billion at the midpoint. Its non-GAAP profit of $2.13 per share was 5% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=27c94ff78d8cd8efc381c4d4b252beaba0d01c38d01f1fbe1e88b079a6adf6f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753786501,
      "headline": "Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations",
      "id": 136117059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Global pharmaceutical company Merck (NYSE:MRK) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.9% year on year to $15.81 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $64.8 billion at the midpoint. Its non-GAAP profit of $2.13 per share was 5% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=27c94ff78d8cd8efc381c4d4b252beaba0d01c38d01f1fbe1e88b079a6adf6f1"
    }
  },
  {
    "ts": null,
    "headline": "Merck Stock Falls After Earnings on Revenue Miss and Job Cuts",
    "summary": "There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.",
    "url": "https://finnhub.io/api/news?id=56988b4b5f18fac54401beac5dab3e3e85c634bbff3ec27e9515aee5e73b022a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753785900,
      "headline": "Merck Stock Falls After Earnings on Revenue Miss and Job Cuts",
      "id": 136117060,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "There is a growing list of challenges to drugs and programs Merck hopes will take up the slack from Keytruda.",
      "url": "https://finnhub.io/api/news?id=56988b4b5f18fac54401beac5dab3e3e85c634bbff3ec27e9515aee5e73b022a"
    }
  },
  {
    "ts": null,
    "headline": "Dow down nearly 125 points on losses for shares of UnitedHealth, Merck",
    "summary": "Dow down nearly 125 points on losses for shares of UnitedHealth, Merck",
    "url": "https://finnhub.io/api/news?id=21b3394e8ff7d4750dc88ec46f65f96740fbd6f9da099238a930fce8c6b569ce",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753785840,
      "headline": "Dow down nearly 125 points on losses for shares of UnitedHealth, Merck",
      "id": 136134663,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow down nearly 125 points on losses for shares of UnitedHealth, Merck",
      "url": "https://finnhub.io/api/news?id=21b3394e8ff7d4750dc88ec46f65f96740fbd6f9da099238a930fce8c6b569ce"
    }
  },
  {
    "ts": null,
    "headline": "Merck to Lay Off Workers and Narrows Guidance as Earnings Fall",
    "summary": "Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, as it looks to redirect resources toward new product launches.",
    "url": "https://finnhub.io/api/news?id=879f15b7112b1a78f1d86417b93f80d2618779d5c238622bfb5ae72525211cd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753785600,
      "headline": "Merck to Lay Off Workers and Narrows Guidance as Earnings Fall",
      "id": 136117061,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck said it is embarking on a multi-year cost-savings plan, which includes cuts to its workforce and real-estate footprint, as it looks to redirect resources toward new product launches.",
      "url": "https://finnhub.io/api/news?id=879f15b7112b1a78f1d86417b93f80d2618779d5c238622bfb5ae72525211cd9"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Q2 Earnings Snapshot",
    "summary": "RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Tuesday reported second-quarter profit of $4.43 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.76. Earnings, adjusted for one-time gains and costs, were $2.13 per share.",
    "url": "https://finnhub.io/api/news?id=f4eea34afbbd8b46baad99b5cee161df2c7c973ae4c8d519f810bad195b94eb4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753785421,
      "headline": "Merck: Q2 Earnings Snapshot",
      "id": 136117062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J. (AP) — Merck & Co. (MRK) on Tuesday reported second-quarter profit of $4.43 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.76. Earnings, adjusted for one-time gains and costs, were $2.13 per share.",
      "url": "https://finnhub.io/api/news?id=f4eea34afbbd8b46baad99b5cee161df2c7c973ae4c8d519f810bad195b94eb4"
    }
  },
  {
    "ts": null,
    "headline": "Merck to cut jobs and costs as demand for Gardasil in China remains weak",
    "summary": "(Reuters) -Merck & Co on Tuesday announced job and cost cuts it said will save $3 billion a year as it posted lower second-quarter results due to continuing weak demand for its Gardasil vaccine in China.  The company said the cost cuts include $1.7 billion in annual savings from the elimination of certain administrative, sales and R&D positions.  Chief Executive Rob Davis said in a press release that the moves \"will redirect investment and resources from more mature areas of our business to our burgeoning array of new growth drivers.\"",
    "url": "https://finnhub.io/api/news?id=f7aae4bc332add81f4e5b653ebdf6fc8099849a86f99250d437cd70b9ee2728f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753785347,
      "headline": "Merck to cut jobs and costs as demand for Gardasil in China remains weak",
      "id": 136117063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "(Reuters) -Merck & Co on Tuesday announced job and cost cuts it said will save $3 billion a year as it posted lower second-quarter results due to continuing weak demand for its Gardasil vaccine in China.  The company said the cost cuts include $1.7 billion in annual savings from the elimination of certain administrative, sales and R&D positions.  Chief Executive Rob Davis said in a press release that the moves \"will redirect investment and resources from more mature areas of our business to our burgeoning array of new growth drivers.\"",
      "url": "https://finnhub.io/api/news?id=f7aae4bc332add81f4e5b653ebdf6fc8099849a86f99250d437cd70b9ee2728f"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results",
    "summary": "RAHWAY, N.J., July 29, 2025--Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results",
    "url": "https://finnhub.io/api/news?id=7904268f83595b9602a8ec95df43013a63d0afb69de78f4bb3ffa2a777322a75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753785000,
      "headline": "Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results",
      "id": 136116973,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., July 29, 2025--Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results",
      "url": "https://finnhub.io/api/news?id=7904268f83595b9602a8ec95df43013a63d0afb69de78f4bb3ffa2a777322a75"
    }
  },
  {
    "ts": null,
    "headline": "Merck will lay off employees and shed some real estate to cut $3 billion in costs",
    "summary": "Merck will lay off employees and shed some real estate to cut $3 billion in costs",
    "url": "https://finnhub.io/api/news?id=10a455f07160c97a84bd5585b3909554fc93b6839222a7a0fb466f760c3b0652",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753783680,
      "headline": "Merck will lay off employees and shed some real estate to cut $3 billion in costs",
      "id": 136134664,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck will lay off employees and shed some real estate to cut $3 billion in costs",
      "url": "https://finnhub.io/api/news?id=10a455f07160c97a84bd5585b3909554fc93b6839222a7a0fb466f760c3b0652"
    }
  },
  {
    "ts": null,
    "headline": "Merck’s $10B Verona Deal: A High-Stakes Play in Respiratory Care",
    "summary": "Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co. unveiled a $10 billion agreement to acquire Verona Pharma at $107 per American Depositary Share, representing a 23% premium over the closing price, in a bold move to bolster its respiratory portfolio ahead […]",
    "url": "https://finnhub.io/api/news?id=dadc2dfc62664c2456f58f697f75871cfc268dee1ac8e517cb5e4d8eca26ec23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753769189,
      "headline": "Merck’s $10B Verona Deal: A High-Stakes Play in Respiratory Care",
      "id": 136117065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co. unveiled a $10 billion agreement to acquire Verona Pharma at $107 per American Depositary Share, representing a 23% premium over the closing price, in a bold move to bolster its respiratory portfolio ahead […]",
      "url": "https://finnhub.io/api/news?id=dadc2dfc62664c2456f58f697f75871cfc268dee1ac8e517cb5e4d8eca26ec23"
    }
  },
  {
    "ts": null,
    "headline": "Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever",
    "summary": "If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%.",
    "url": "https://finnhub.io/api/news?id=804e7c1014333557f0f08020643bf2a5c45ab61dbdd25651723cd5752e44fd7b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753747500,
      "headline": "Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever",
      "id": 136113403,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%.",
      "url": "https://finnhub.io/api/news?id=804e7c1014333557f0f08020643bf2a5c45ab61dbdd25651723cd5752e44fd7b"
    }
  }
]